Laboratorio Pablo Cassara of Argentina is organizing a network of small and medium-sized companies to make and distribute drugs in the Mercosur trading block (Argentina, Brazil, Paraguay and Uruguay), as well as Chile, Bolivia, Ecuador and Peru. The venture will offset competition from major international players in South America, it was noted.
Cassara has so far signed production agreements with Ewe and Austral of Argentina, and with Laboratorio Cristalia of Brazil. Distribution agreements have been signed with Drimant and Promofarma of Uruguay, Cristalia and Promofarma of Brazil, Euderma of Paraguay and Danes of Chile.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze